Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.
Bergers G; Song S; Meyer-Morse N; Bergsland E; Hanahan D; The Journal Of Clinical Investigation, 2003, vol. 111, issue 9, p 1287, ISSN 00219738. ISBN 00219738.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef